Semiconductors at All-Time Highs vs Weak Big Tech — Two Faces of NASDAQ

Semiconductors at All-Time Highs vs Weak Big Tech — Two Faces of NASDAQ

Semiconductors at All-Time Highs vs Weak Big Tech — Two Faces of NASDAQ

·3 min read
Share

SMH returned to all-time highs. On the same day, Tesla got rejected at 364 and dropped hard.

Same market, same session, completely different directions. It's rare to see this kind of divergence between semiconductors and Big Tech within the NASDAQ. The gap deserves attention.

Semiconductors: The Market's Pillar Is Back

When SMH broke below 372, plenty of voices called the top of the semiconductor cycle. It dropped to 360. Then the moment it remounted, it turned into a beast. Now it's back at all-time highs — in the middle of a war and peak uncertainty.

The individual names tell an even more compelling story.

NVIDIA (NVDA): Recovered to 184. Sitting above its 200-day SMA, maintaining the trend. Hold above this level and upside is open; lose it and you're targeting the gap fill. Simple trade either way.

Broadcom (AVGO): Attempting to break through massive resistance at 350–353. Clear this and 374 comes into view, then back to all-time highs. The additional Google TPU contract news adds to the bullish case.

TSMC (TSM): The most dramatic recovery. A head-and-shoulders pattern formed with support holding at 316, and it's now back at 370 — inching toward its all-time high.

Micron (MU): Surged from 310 to 410. Above 414, targets open to 425–430, and aggressively to 440.

StockRecent LowCurrent Rangevs All-Time High
NVDA~160184Near ATH
AVGO~320350–353Near ATH if 374 clears
TSM316370Close to ATH
MU310410+430–440 target
ASML~13501407+1450–1490 target
Intel4350+Highest since 2021
AMD~200~230Gap fill in progress

SanDisk back at all-time highs. ASML above 1,407 looking toward 1,450–1,490. Intel climbed from 43 back above 50, hitting levels not seen since 2021. AMD filling the gap toward 230.

Saying semiconductors are going berserk is not an exaggeration.

Big Tech (Mag 7): Cracks Are Showing

The Magnificent Seven paint a different picture. "Mixed" is the most accurate description.

Tesla (TSLA): The weakest name in the group. Rejected precisely at the 364 key level this morning, then slid all day. An ugly chart by any technical standard.

Meta (META): Bearish all morning, then spiked on a mid-day AI product launch, only to give most of it back. Below 600, this stock looks very weak. The timing of the mid-session AI release was itself unusual.

Microsoft (MSFT): Rejected at 385, spent the entire day pinned against resistance, and finally broke down into the close. A textbook short setup that played out perfectly.

Apple (AAPL): Showed some recovery, but relative to semis, Big Tech's strength falls short by a wide margin.

What This Divergence Means

The core logic is straightforward. If semis stay strong, NASDAQ is not a short.

SMH is the market's pillar. It powered through war, surging oil, political uncertainty — every headwind imaginable — to reach all-time highs. As long as semiconductors maintain this momentum, a full NASDAQ collapse is unlikely.

The danger signal looks like this: if semiconductors start rolling over — SMH breaks back below 372, NVDA loses the 200-day — the picture changes entirely. Combined with Big Tech weakness, NASDAQ downside risk escalates rapidly.

For now, semiconductor strength is offsetting Big Tech's cracks. But how long this balance holds is the key variable that determines market direction next quarter.

FAQ

Q: Is it too late to enter SMH near all-time highs? A: Risk-reward isn't optimal at the top. Either wait for a pullback, or if entering, use strict stop-losses and size positions conservatively. The structural bull case for semis remains valid long-term, but geopolitical risk could trigger sharp pullbacks at any time.

Q: Which Mag 7 stock recovers first? A: Apple looks technically healthiest right now. Tesla is the weakest, with Meta and Microsoft stuck against resistance. But in a market where one overnight headline reshuffles the entire ranking, conviction on sequencing is low.

Share

Ecconomi

Finance & Economics major at a U.S. university. Securities report analyst.

Learn more
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Investment decisions should be made at your own discretion and risk.

More in this Category

Previous Posts

Ecconomi

A professional financial content platform providing in-depth analysis and investment insights on global financial markets.

Navigation

The content on this site is for informational purposes only and should not be construed as investment advice or financial guidance. Investment decisions should be made based on your own judgment and responsibility.

© 2026 Ecconomi. All rights reserved.